QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ESPR

QT75Esperion Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
3.15
-0.02-0.63%
OverviewShort InterestFilings
ESPRQT75Esperion Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
3.15-0.63%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-0.06
Insider Own10.58%
Shs Outstand257.69M
Perf Week0.00%
Market Cap659.07MForward P/E11.59EPS next Y0.27Insider Trans-0.02%Shs Float-Perf Month0.64%
Enterprise Value755.54MPEG-EPS next Q-0.02Inst Own-Short Float-Perf Quarter21.15%
Income-6129357.00P/S1.58EPS this Y33.33%Inst Trans-Short Ratio-Perf Half Y-15.09%
Sales418.23MP/B-EPS next Y779.18%ROA-1.60%Short Interest-Perf YTD-14.86%
Book/sh-1.20P/C-EPS next 5Y-ROE1.99%52W High4.18 -24.64%Perf Year188.99%
Cash/sh0.61P/FCF-EPS past 3/5Y-ROIC30.77%52W Low0.95 231.93%Perf 3Y-
Dividend Est.-EV/EBITDA18.94Sales past 3/5Y75.15% 12.07%Gross Margin65.00%Volatility0.45% 0.39%Perf 5Y-
Dividend TTM-EV/Sales1.81EPS Y/Y TTM78.57%Oper. Margin18.12%ATR (14)0.03Perf 10Y-
Dividend Ex-Date-Quick Ratio1.18Sales Y/Y TTM25.60%Profit Margin-1.77%RSI (14)67.29Recom3.00
Dividend Gr. 3/5Y-Current Ratio1.53EPS Q/Q52.38%SMA200.32%Beta1.91Target Price3.19
Payout0.00%Debt/Eq-0.82Sales Q/Q23.08%SMA5013.37%Rel Volume1.21Prev Close3.17
Employees304LT Debt/Eq-1.52EarningsAug 04SMA2004.34%Avg Volume14.48MPrice3.15
IPO DateJun 26, 2013Option/ShortYes / YesEPS/Sales Surpr.-150.00% -5.88%Net Debt/EBITDA2.42Volume17,492,654Change-0.63%
Analyst Ratings
DateActionAnalystRatingTarget
May-04-26DowngradeNeedhamBuy → Hold
May-01-26ReiteratedJefferiesHold$3.28
May-01-26ReiteratedPiper Sandler$9.00 → $3.16
May-01-26ReiteratedH.C. Wainwright$3.16
May-01-26ReiteratedCantor Fitzgerald$9.00 → $3.16
May-01-26DowngradeHC Wainwright & Co.Buy → Neutral
Nov-24-25InitiatedPiper SandlerOverweight$9.00
Sep-25-25ReiteratedCantor Fitzgerald$7.00 → $9.00
Dec-17-24InitiatedCantor FitzgeraldOverweight$8.00
Jun-20-24DowngradeB of A SecuritiesNeutral → Underperform
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue417403332
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A14712969
Gross Profit273274264
Selling, General and Administrative Excl. Other166166163
Research and Development444846
Other Operating Expense-1400
Operating Income756054
Interest Expense458559
Unusual Expense
———
Non-Operating Income (Expense)35-347
Net Income Before Taxes-5-21-52
Income Taxes220
Consolidated Net Income-7-23-52
Net Income From Continuing Operations-7-23-52
Net Income-7-23-52
EPS (Recurring)-0.02-0.11-0.28
EPS (Basic, Before Extraordinaries)-0.02-0.11-0.28
EPS (Diluted)-0.06-0.11-0.28
EBITDA40648
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio1.901.91—
Gross Margin65.4767.9979.52
Operating Margin17.9914.8916.27
Net Margin-1.68-5.71-15.66
Shares Outstanding251208187
Market Capitalization791770—
Operating Lease Expense
———
Insider Trading Volume
$3.30$2.98$2.66$2.34$2.02● Close Price0.00K57.00K114.00K171.00K228.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Looker BenjaminChief Legal OfficerMar 17 '26Sale2.705,70815,429679,348Mar 18 12:00 AM
Koenig Sheldon L.President and CEOMar 17 '26Sale2.7225,57869,5472,172,699Mar 18 12:00 AM
Halladay BenjaminChief Financial OfficerMar 17 '26Sale2.716,42417,377713,602Mar 18 12:00 AM
Looker BenjaminGeneral CounselJan 20 '26Sale2.881,6894,868384,216Jan 21 12:00 AM
Koenig Sheldon L.President and CEODec 17 '25Sale3.6748,244177,2001,470,587Dec 18 12:00 AM
Halladay BenjaminChief Financial OfficerDec 17 '25Sale3.677,33726,905467,525Dec 18 12:00 AM
Looker BenjaminGeneral CounselDec 17 '25Sale3.676,51723,898385,905Dec 18 12:00 AM
Looker BenjaminGeneral CounselSep 17 '25Sale2.806,26717,573393,670Sep 18 12:00 AM
Koenig Sheldon L.President and CEOSep 17 '25Sale2.7928,42779,2541,518,831Sep 18 12:00 AM
Halladay BenjaminChief Financial OfficerSep 17 '25Sale2.817,04619,785474,862Sep 18 12:00 AM
Looker BenjaminGeneral CounselJul 17 '25Sale1.131,3041,470399,937Jul 18 12:00 AM
Halladay BenjaminChief Financial OfficerJul 17 '25Sale1.111112474,462Jul 18 12:00 AM
Looker BenjaminGeneral CounselJun 17 '25Sale1.156,4227,398401,241Jun 18 12:00 AM
Koenig Sheldon L.President and CEOJun 17 '25Sale1.1130,47433,7961,541,488Jun 18 12:00 AM
Halladay BenjaminChief Financial OfficerJun 17 '25Sale1.157,2298,328474,473Jun 18 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR